Hrustanovic Gorjan Insider Trades

Insider Trading History

Track insider trading activity for Hrustanovic Gorjan. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $1.17M 16,000 shares
Last Trade
Jun 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$744k 16,000 shares
$46.47
$73.21
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
Director
Holding Value $254k 24,150 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$98.5k 24,150 shares
$4.08
$10.51
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $1.17M 16,000 shares
Last Trade
Jun 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$499k 16,000 shares
$31.20
$73.21
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
Director
Holding Value $242k 23,000 shares
Last Trade
Jun 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$284k 23,000 shares
$12.36
$10.51
Rain Oncology
Rain Oncology RAIN
Director
Holding Value $0 0 shares
Last Trade
Jan 26, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$66.6k 55,000 shares
$1.21
$2.20
Rain Oncology
Rain Oncology RAIN
Director
Holding Value $77.2k 35,000 shares
Last Trade
Aug 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$42.4k 35,000 shares
$1.21
$2.20
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
Director
Holding Value $226k 21,520 shares
Last Trade
Jun 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$169k 21,520 shares
$7.84
$10.51
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $879k 12,000 shares
Last Trade
Jun 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$332k 12,000 shares
$27.67
$73.21
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
Holding Value $226k 21,520 shares
Last Trade
Jun 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$77.7k 21,520 shares
$3.61
$10.51
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
Director
Holding Value $226k 21,520 shares
Last Trade
Jun 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$73.8k 21,520 shares
$3.43
$10.51
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $879k 12,000 shares
Last Trade
Jun 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$340k 24,000 shares
$14.18
$73.21
Rain Oncology
Rain Oncology RAIN
Director
Holding Value $44.1k 20,000 shares
Last Trade
Jun 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.8k 20,000 shares
$2.44
$2.20
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $1.47M 20,063 shares
Last Trade
Jun 16, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$985k 20,063 shares
$49.10
$73.21
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
Holding Value $226k 21,520 shares
Last Trade
Jun 09, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$595k 21,520 shares
$27.66
$10.51
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
Director
Holding Value $226k 21,520 shares
Last Trade
Nov 18, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$10.51
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $2.94M 40,127 shares
Last Trade
Aug 20, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$73.21

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up